Which Helicobacter pylori-positive dyspeptics are likely to respond symptomatically to empirical H. pylori eradication?

Objective: To identify which Helicobacter pylori-positive dyspeptic patients have an increased likelihood of having peptic ulcer and may thus be more likely to benefit from empirical H. pylori eradication therapy.Methods: 622 out of 740 consecutive dyspeptic subjects (median age 45 years, range 14-9...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Gastroenterology & Hepatology Vol. 10; no. 3; pp. 265 - 269
Autores principales: Asante, Maxwell A., Mendall, Michael A., Northfield, Timothy C., Asante, M A, Mendall, M A, Northfield, T C
Formato: research Journal Article
Publicado: Lippincott Williams & Wilkins Mar1998
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=110640851&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 110640851
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0954691X
        8CE
      jtl: European Journal of Gastroenterology & Hepatology
      issn: 0954691X
      maglogo: N
    pubinfo:
      dt: Mar1998
      vid: 10
      iid: 3
      pid: 5086
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        110640851
        110640851
        NLM9585033
        110640851
        10.1097/00042737-199803000-00014
        NLM9585033
        110640851
      ppf: 265
      ppct: 4
      formats:
      tig:
        atl: Which Helicobacter pylori-positive dyspeptics are likely to respond symptomatically to empirical H. pylori eradication?
      aug:
        au:
          Asante, Maxwell A.
          Mendall, Michael A.
          Northfield, Timothy C.
          Asante, M A
          Mendall, M A
          Northfield, T C
        affil: Department of Gastroenterology, Endocrinology and Metabolism, St George's Hospital Medical School, London, UK
      sug:
        subj:
          Dyspepsia Drug Therapy
          Helicobacter Pylori
          Peptic Ulcer Epidemiology
          Helicobacter Infections Drug Therapy
          Predictive Value of Tests
          Male
          Human
          Aged, 80 and Over
          Middle Age
          Smoking
          Adolescence
          Aged
          Risk Factors
          Dyspepsia Microbiology
          Sensitivity and Specificity
          Female
          Adult
          Validation Studies
          Comparative Studies
          Evaluation Research
          Multicenter Studies
          Aged, 80 & over
          Middle Aged: 45-64 years
          Adolescent: 13-18 years
          Aged: 65+ years
          Adult: 19-44 years
          Male
          Female
      ab: Objective: To identify which Helicobacter pylori-positive dyspeptic patients have an increased likelihood of having peptic ulcer and may thus be more likely to benefit from empirical H. pylori eradication therapy.Methods: 622 out of 740 consecutive dyspeptic subjects (median age 45 years, range 14-91, 51% male) attending for rapid access endoscopy were eligible for the study. Demographic data and endoscopic findings were recorded. H. pylori status was determined by urease and histology.Results: In all age groups, peptic ulcers were commoner in males than females [44% (85/195) vs 23% (32/139), P < 0.001] and in smokers than non-smokers [47% (46/97) vs 32% (50/159), P < 0.05]. Males, heavy smokers and those with a family history of peptic ulcer had increased adjusted odds of having a peptic ulcer (2.59, 1.96 and 1.90, respectively). Corresponding odds ratios for those aged under 45 were 2.59, 0.94 and 2.52. In H. pylori-positive dyspepsia, being a male who either smoked heavily or had a family history of peptic ulcer gave a sensitivity and positive predictive value for peptic ulcer of 86 and 45% for all age groups and 85 and 49% for those aged under 45.Conclusion: Male H. pylori dyspeptics who smoke >10 cigarettes per day and/or have a family history of peptic ulcer are likely to have peptic ulcer and are thus likely to benefit from empirical eradication therapy.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N